Image Credit: STAT News
STAT+: Jiangsu Hengrui, a preferred China partner for U.S. biotech, hints at more deals
One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui, emphasized its global ambitions and plans for more dealmaking at #JPM25.